Injae Chung

993 total citations
23 papers, 657 citations indexed

About

Injae Chung is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Injae Chung has authored 23 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Pharmacology. Recurrent topics in Injae Chung's work include Virus-based gene therapy research (5 papers), ATP Synthase and ATPases Research (5 papers) and Mitochondrial Function and Pathology (4 papers). Injae Chung is often cited by papers focused on Virus-based gene therapy research (5 papers), ATP Synthase and ATPases Research (5 papers) and Mitochondrial Function and Pathology (4 papers). Injae Chung collaborates with scholars based in United Kingdom, United States and South Korea. Injae Chung's co-authors include Judy Hirst, Edward Bresnick, Alan Eastman, Hannah R. Bridges, David Parry, John J. Wright, Albert Deisseroth, James N. Blaza, Olivier Biner and Huagang Hou and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Injae Chung

22 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Injae Chung United Kingdom 15 481 152 66 63 61 23 657
Younes Mokrab United Kingdom 14 398 0.8× 270 1.8× 46 0.7× 46 0.7× 22 0.4× 25 769
Yves Dubaquié United States 13 622 1.3× 191 1.3× 39 0.6× 48 0.8× 32 0.5× 16 808
Mark Sales United Kingdom 13 300 0.6× 131 0.9× 99 1.5× 86 1.4× 24 0.4× 15 608
Adrián César‐Razquin Austria 7 396 0.8× 188 1.2× 32 0.5× 30 0.5× 28 0.5× 8 638
Natalie O. Karpinich United States 14 600 1.2× 238 1.6× 29 0.4× 20 0.3× 41 0.7× 16 888
Mark Agostino Australia 16 778 1.6× 165 1.1× 80 1.2× 33 0.5× 24 0.4× 41 1.1k
Suhong Yu China 16 382 0.8× 217 1.4× 56 0.8× 43 0.7× 23 0.4× 31 773
Weihong Li China 14 423 0.9× 70 0.5× 27 0.4× 23 0.4× 39 0.6× 38 659
Yutaro Azuma Japan 15 463 1.0× 77 0.5× 43 0.7× 15 0.2× 53 0.9× 42 756
Emile G. Plise United States 17 493 1.0× 312 2.1× 42 0.6× 115 1.8× 31 0.5× 39 876

Countries citing papers authored by Injae Chung

Since Specialization
Citations

This map shows the geographic impact of Injae Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Injae Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Injae Chung more than expected).

Fields of papers citing papers by Injae Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Injae Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Injae Chung. The network helps show where Injae Chung may publish in the future.

Co-authorship network of co-authors of Injae Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Injae Chung. A scholar is included among the top collaborators of Injae Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Injae Chung. Injae Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Injae, Yizhou Yu, Samantha H. Y. Loh, et al.. (2023). The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors. Biology Direct. 18(1). 43–43. 7 indexed citations
2.
Milenkovic, Dusanka, Johannes F. Hevler, Injae Chung, et al.. (2023). Preserved respiratory chain capacity and physiology in mice with profoundly reduced levels of mitochondrial respirasomes. Cell Metabolism. 35(10). 1799–1813.e7. 33 indexed citations
3.
Agip, Ahmed-Noor A., Injae Chung, Álvaro Sánchez-Martínez, Alexander J. Whitworth, & Judy Hirst. (2023). Cryo-EM structures of mitochondrial respiratory complex I from Drosophila melanogaster. eLife. 12. 21 indexed citations
4.
Grba, Daniel N., Injae Chung, Hannah R. Bridges, Ahmed-Noor A. Agip, & Judy Hirst. (2023). Investigation of hydrated channels and proton pathways in a high-resolution cryo-EM structure of mammalian complex I. Science Advances. 9(31). eadi1359–eadi1359. 20 indexed citations
5.
Chung, Injae, John J. Wright, Hannah R. Bridges, et al.. (2022). Cryo-EM structures define ubiquinone-10 binding to mitochondrial complex I and conformational transitions accompanying Q-site occupancy. Nature Communications. 13(1). 2758–2758. 53 indexed citations
6.
Chung, Injae, Daniel N. Grba, John J. Wright, & Judy Hirst. (2022). Making the leap from structure to mechanism: are the open states of mammalian complex I identified by cryoEM resting states or catalytic intermediates?. Current Opinion in Structural Biology. 77. 102447–102447. 25 indexed citations
7.
Chung, Injae, Riccardo Serreli, Jason B. Cross, et al.. (2021). Cork-in-bottle mechanism of inhibitor binding to mammalian complex I. Science Advances. 7(20). 31 indexed citations
8.
Harvey, Robert F., Kenneth R. Pryde, Riccardo Serreli, et al.. (2020). Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. eLife. 9. 15 indexed citations
9.
Wang, Chia‐Jung, et al.. (2017). Airway Microbial Diversity is Inversely Associated with Mite-Sensitized Rhinitis and Asthma in Early Childhood. Scientific Reports. 7(1). 1820–1820. 55 indexed citations
10.
Chung, Injae. (2014). A Proposal to Change Welfare Policy Principles for Agent Orange Exposed Korean Veterans. Korean Journal of Environmental Health Sciences. 40(2). 157–170. 1 indexed citations
11.
12.
Chung, Injae, et al.. (2011). Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites. Molecular Cancer Therapeutics. 11(2). 427–438. 100 indexed citations
13.
Fu, Siqing, F. García‐Sánchez, Injae Chung, et al.. (2009). Results of retroviral and adenoviral approaches to cancer gene therapy. Stem Cells. 16(S2). 247–250. 10 indexed citations
14.
15.
Chung, Injae & Albert Deisseroth. (2004). Recombinant adenoviral vector containing tumor-specific l-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test. Archives of Pharmacal Research. 27(6). 633–639. 5 indexed citations
16.
Chung, Injae, et al.. (2002). No role of protected region b of human cytochrome P4501A2 gene (CYP1A2) as an AP-1 response element. Archives of Pharmacal Research. 25(3). 375–380. 1 indexed citations
17.
Chung, Injae, Peter E. Schwartz, Ronald G. Crystal, et al.. (1999). Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Therapy. 6(2). 99–106. 43 indexed citations
18.
Chung, Injae & Edward Bresnick. (1997). Identification of Positive and Negative Regulatory Elements of the Human Cytochrome P4501A2 (CYP1A2) Gene. Archives of Biochemistry and Biophysics. 338(2). 220–226. 45 indexed citations
19.
Fu, Siqing, et al.. (1997). Adenoviral Vectors and Hematopoietic Cells. Blood. 89(4). 1460–1462. 8 indexed citations
20.
Chung, Injae & Edward Bresnick. (1995). Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins.. Molecular Pharmacology. 47(4). 677–685. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Younes Mokrab Breakdown of academic impact, for papers by Yves Dubaquié Breakdown of academic impact, for papers by Mark Sales Breakdown of academic impact, for papers by Adrián César‐Razquin Breakdown of academic impact, for papers by Natalie O. Karpinich Breakdown of academic impact, for papers by Mark Agostino Breakdown of academic impact, for papers by Suhong Yu Breakdown of academic impact, for papers by Weihong Li Breakdown of academic impact, for papers by Yutaro Azuma Breakdown of academic impact, for papers by Emile G. Plise
Rankless by CCL
2026